glp-1 weight loss expectations medications are changing the landscape of obesity treatment, but having realistic is really important. Clinical trials showed average weight loss of approximately: • ~15% body weight with semaglutide • ~ Rx Trends: Real-World Data on

Metformin Metformin is not FDA-approved for weight loss, but it produces modest weight reduction (2-3% of body weight) as a side effect of its primary mechanism, improving insulin sensitivity and reducing hepatic glucose production

Recalls & Warnings June 04, 2012 FDA Warning on Supplement for Pain Relief On June 1, 2012, the U.S

GLP-1 medications offer real benefits for weight and blood sugar management but those benefits should not come at the cost of bone density, muscle function, or immune health

Jay Bacow: Let's hope they don't lose the first game and make him cry like you did a few years ago

They should want a scientific evaluation before putting anything in their body, he said.